Mona R.E. Abdel-Halim
Cairo University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mona R.E. Abdel-Halim.
International Journal of Dermatology | 2005
Mohammad Ali El-Darouti; Salonas A. Marzouk; Mona R.E. Abdel-Halim; Anoud Z. Zidan; Marwa M. Fawzy
Basaloid follicular hamartoma (BFH) is a unique benign follicular hamartoma characterized by variable clinical presentations, identical histologic features and possible associations with numerous disorders.
International Journal of Dermatology | 2001
Mohammad A. El-Darouty; Salonas A. Marzouk; Mona R.E. Abdel-Halim; Mohammad H. M. El-Komy; Heba M. Mashaly
Case 1 A 6‐month‐old boy presented to our clinic with a scalp lesion dating since birth ( Fig. 1 ). The lesion was in the form of an erythematous, dome‐shaped nodule, measuring around 1.5 cm in diameter and having a slightly irregular surface. The lesion was nonitchy, nontender, and showed limited mobility. Our clinical differential diagnosis included: meningocele, hemangioma, dermoid cyst, and apocrine nevus. A computed tomography (CT) scan was performed to exclude possible intracranial connection, and the lesion was surgically excised.
International Journal of Dermatology | 2006
Mohammad Ali El-Darouti; Salonaz A. Marzouk; Mona R.E. Abdel-Halim
Muckle–Wells syndrome (MWS) is a rare syndrome, characterized by chronic recurrent urticaria, often combined with fever, chills, rigors, malaise, and arthralgia. Progressive sensorineural deafness, and, in approximately one third of the patients, amyloidosis of the kidneys as well as of other organs may occur. It was first described in 1962 by Muckle and Wells.
American Journal of Dermatopathology | 2010
Hoda Rasheed; Marwa M.T. Fawzi; Mona R.E. Abdel-Halim; Amal A.M. Eissa; Nahla Mohammed Salem; Soheir Mahfouz
Matrix metalloproteinase-9 (MMP-9) has been correlated with poor clinical outcome in various malignancies and is associated with enhanced tumor growth and dissemination through its role in angiogenesis. This study was carried out to review the immunohistological staining of MMP-9 in skin lesions of different stages of mycosis fungoides (MF). The study was carried on 22 patients with MF and 10 healthy controls. Immunohistochemical staining using MMP-9 monoclonal anti-human antibodies was performed to determine the intensity of expression and distribution pattern of MMP-9 in MF lesions and in normal control skin. The general intensity of expression of MMP-9 was found to be significantly higher in cases with MF than in controls, and it increased in direct proportion to the increase in disease severity, being greatest in the tumor stages. A significantly greater number of blood vessels were found in cases with MF when compared with controls, and the MMP-9 expression by endothelial cells was significantly higher in endothelial cells within tumor cell aggregates than in endothelial cells outside the tumor cell aggregates. This study raises the possibility that MMP-9 may play an important role in the development of MF lesions, and its significantly higher expression in tumor stages may point to a possible role in disease progression. Further studies are needed to validate these findings and to assess the possible therapeutic role of drugs targeting MMP-9 in the treatment of MF.
Journal of The American Academy of Dermatology | 2010
Mohammad Ali El-Darouti; Heba M. Mashaly; Eman El-Nabarawy; Amal A.M. Eissa; Mona R.E. Abdel-Halim; Marwa M.T. Fawzi; Nermine H. El-Eishi; Sherine O. Tawfik; Naglaa S. Zaki; Anoud Z. Zidan; Mohammad Abdelaziz; Mai M.T. Fawzi; Olfat G. Shaker
BACKGROUND Leukocytoclastic vasculitis (LCV) and necrolytic acral erythema (NAE) are skin disorders associated with hepatitis C virus (HCV) infection. However, they have not been found to occur simultaneously in the same patient. OBJECTIVE We sought to analyze the role of serum HCV-RNA levels and HCV genotype in the pathogenesis of both LCV and NAE in an attempt to assess whether these two parameters play a role in mutual exclusivity of LCV and NAE in the same patient. METHODS The study included 11 patients with LCV and 13 with NAE, all of whom were infected with HCV. All 24 patients were evaluated for the quantitative levels of HCV-RNA, using real-time polymerase chain reaction. HCV genotyping was performed on 10 patients in each group (N = 20). RESULTS Patients with LCV had a higher prevalence of moderate and high levels of HCV-RNA viremia (P = .038) than those with NAE. However, there was no significant difference in HCV genotype between LCV and NAE groups (P = .211). LIMITATIONS Small number of cases is a limitation. CONCLUSION Viral load seems to play a role in determining the response of the skin to HCV infection. High levels of HCV viremia were found to be significantly associated with LCV but not with NAE. HCV viremia may play a role in the development of LCV in HCV-infected patients.
Journal of Dermatological Treatment | 2011
Medhat El-Mofty; Mohamed El-Darouti; Hoda Rasheed; Dalia Ahmed Bassiouny; Mona R.E. Abdel-Halim; Naglaa S. Zaki; Ghada M. El-Hanafy; Heba H El-hadidi; Omar A. Azzam; Amany Z. El-Ramly; Marwa M. Fawzy
Abstract Background: Conventional therapy of extensive psoriasis is effective but has complications. Biologics are safer but expensive. Objective: To assess the efficacy of sulfasalazine and pentoxifylline, which have TNF antagonizing and anti-proliferative action in the treatment of psoriasis. Methods: In this randomized controlled trial, 32 patients with extensive psoriasis were divided into four groups: group A received sulfasalazine; group B received pentoxifylline; group C received both drugs; and group D received methotrexate. The Psoriasis Area and Severity Index (PASI) score was done at weeks 0, 2, 4, 6 and 8. Results: A significant reduction in PASI score occurred in groups C and D (p = 0.043 and 0.018, respectively). A significantly higher percentage of PASI score reduction occurred in group D compared with groups A, B and C (p = 0.006, 0.003 and 0.030, respectively). An excellent response occurred in one patient (14.3%) in group D. A very good response occurred in two patients (22.2%) in group C, and in five patients (71.4%) in group D. A moderate response occurred in three patients (37.5%) in group A, one patient (12.5%) in group B, and one patient (14.3%) in group D. Conclusion: Although incomparable to methotrexate, combined sulfasalazine and pentoxifylline produced a good response in cases of extensive psoriasis. Multicentre studies are needed to validate these results.
British Journal of Dermatology | 2008
Marwa M.T. Fawzi; Sherine O. Tawfik; Amal A.M. Eissa; Mohamed El-Komy; Mona R.E. Abdel-Halim; Olfat G. Shaker
Background Morphoea (scleroderma) is a chronic disorder characterized by circumscribed sclerotic plaques with the hallmark of increased fibroblast activation and fibrosis. Through its effect on connective tissue cells and immune cells, insulin‐like growth factor (IGF)‐I has been found to play a role in some autoimmune connective tissue diseases and has been implicated in the pathogenesis of several fibrotic disorders.
European Journal of Dermatology | 2012
Olfat G. Shaker; Mona R.E. Abdel-Halim
BACKGROUND Direct intercellular signaling, which controls keratinocyte behavior, proliferation and differentiation, occurs through gap junctions. Altered expression of connexins may play a role in the development of psoriatic lesions. OBJECTIVES We estimated connexin 26 (Cx26) mRNA in psoriatic patients and investigated whether the standard therapeutic modalities (methotrexate and PUVA) exert their anti-psoriatic activity partially through altering Cx26 mRNA levels. We also detected Cx26 in skin biopsies by immunohistochemistry. RT-PCR measured Cx26 mRNA levels in 24 chronic plaque psoriasis patients. Group A received intramuscular methotrexate and group B was treated by PUVA for ten weeks, each followed by measurement of Cx26 mRNA levels and immunohistochemistry. Twelve healthy volunteers served as controls. RESULTS Cx26 mRNA expression was significantly higher in the patients before treatment than in controls (P<0.001). Post treatment levels were significantly lower than pre-treatment levels (P<0.001), however, significantly higher than in controls (P<0.001). Methotrexate and PUVA caused significant reductions in Cx26 mRNA expression (P=0.002, P=0.028 respectively). Post treatment levels were slightly significantly lower in the methotrexate group than in the PUVA group (P=0.046). The reduction in Cx26 mRNA expression was significantly positively correlated with the clinical improvement of the psoriatic plaque (P=0.002). Immunostaining of Cx26 decreased after treatment. CONCLUSION Altered expression of the gap junction protein Cx26 may have a role in the development of the psoriatic phenotype. Both methotrexate and PUVA significantly lowered the expression of Cx26 mRNA and protein.
Journal of The European Academy of Dermatology and Venereology | 2006
Mohammad Ali El-Darouti; Salonaz A. Marzouk; N. Nabil; Mona R.E. Abdel-Halim; Mohamed El-Komy; M. Abdel-Latif
JEADV 2006, 18, 602–634
International Journal of Dermatology | 2006
Mohammad Ali El-Darouti; Soliman Hussein; Salonaz A. Marzouk; Naglaa Nabil; Nahla S. Hunter; Duaa Mahgoub; Nermine H. El-Eishi; Mona R.E. Abdel-Halim
Background Several clinical and laboratory observations point to the possible microscopical affection of normal‐looking skin in leprosy.